Advertisement

Topics

What’s Militia Hill Ventures’ take on biotech, cancer therapy investment? (Q&A)

16:10 EDT 29 Jun 2017 | MedCity News

business deal

Jane Holmes Hollingsworth, Militia Hill Ventures cofounder and managing partner, will take part in a panel discussion on investment in cancer therapies at the MedCity CONVERGE conference in Philadelphia July 31-August 1.

Original Article: What’s Militia Hill Ventures’ take on biotech, cancer therapy investment? (Q&A)

NEXT ARTICLE

More From BioPortfolio on "What’s Militia Hill Ventures’ take on biotech, cancer therapy investment? (Q&A)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...